Development of a Physiologically-Based Pharmacokinetic Model for Coproporphyrin I (CP-I) Using the Open Systems Pharmacology Software Suite (PK-Sim and MoBi) for assessment of OATP1B-based DDIs

ACoP14 (Nov 2023), Poster: W-071
Kanacher T, Pellowe M, Kovar C, Eriksson J, Huang F, Wu F, Sailer R, Busse D, Gómez-Mantilla JD.

This poster describes a Coproporphyrin (CP-I) PBPK-model, which can be used in the freely accessible Open Systems Pharmacology Suite (PK-Sim and MoBi) to assess potential drug-drug interaction of new therapeutic drugs via OATP1B.

Pharmetheus Affiliates

Portrait-of-Tobias-Kanacher-Pharmetheus
Senior Consultant

Tobias Kanacher

See bio
Portrait-of-Moriah-Pellowe_Pharmetheus
Consultant

Moriah Pellowe

See bio
Portrait-of-Christina-Kovar_Pharmetheus
Associate Consultant

Christina Kovar

See bio
Portrait-of-Johanna-Eriksson_Pharmetheus
Consultant

Johanna Eriksson

See bio